CCAP Stock Analysis: Crescent Capital BDC | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 342m USD | 12M Return: -14.5% | US2256551092 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.66M
EPS Trend: -96.5%
Qual. Beats: 0
Rev. Trend: -73.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality
Crescent Capital BDC, Inc. (CCAP) is a business development company (BDC) focused on direct investments within the U.S. middle market. The firm primarily engages in private equity buyouts and the provision of specialized loan products to established mid-sized enterprises.
Operating under the Investment Company Act of 1940, BDCs like CCAP are required to distribute at least 90% of their taxable income to shareholders to maintain their tax-advantaged status. This business model focuses on generating income through senior secured debt and equity co-investments, typically targeting companies with resilient cash flows. For those analyzing dividend sustainability and portfolio composition, further data is available on ValueRay.
- Net interest margin expansion driven by floating rate senior secured loan portfolio
- Middle market credit quality stability amid tightening monetary policy and economic cycles
- Strategic acquisition of First Eagle BDC expands asset base and scale
- Dividend coverage ratios supported by consistent fee income and investment yields
- Potential credit losses in sponsor-backed portfolio companies impact net asset value
| Net Income: 3.42m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.95 > 1.0 |
| NWC/Revenue: 5.89% < 20% (prev -2.43%; Δ 8.33% < -1%) |
| CFO/TA 0.02 > 3% & CFO 33.1m > Net Income 3.42m |
| Net Debt (837.6m) to EBITDA (8.86m): 94.59 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.8m) vs 12m ago -0.58% < -2% |
| Gross Margin: 72.92% > 18% (prev 47.22%; Δ 25.70% > 0.5%) |
| Asset Turnover: 7.85% > 50% (prev 6.31%; Δ 1.55% > 0%) |
| Interest Coverage Ratio: 0.09 > 6 (EBIT TTM 5.42m / Interest Expense TTM 57.4m) |
| A: 0.00 (Total Current Assets 43.9m - Total Current Liabilities 36.4m) / Total Assets 1.60b |
| B: -0.16 (Retained Earnings -251.0m / Total Assets 1.60b) |
| C: 0.00 (EBIT TTM 5.42m / Avg Total Assets 1.61b) |
| D: 0.69 (Book Value of Equity 652.9m / Total Liabilities 948.5m) |
| Altman-Z'' = 0.26 = B |
As of November 11, 2026, the stock is trading at USD 10.38 with a total of 536,801 shares traded. Over the past week, the price has changed by +11.02%, over one month by +13.57%, over three months by -7.58% and over the past year by -14.49%.
Current recommended Stop Loss: 10.00 (which is 3.7% or 1.5 ATR below the current price).
Crescent Capital BDC has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold CCAP.
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12 | 15.2% |
P/E Forward = 6.8027
P/S = 2.1768
P/B = 0.5271
P/EG = 0.8918
Revenue TTM = 126.8m USD
EBIT TTM = 5.42m USD
EBITDA TTM = 8.86m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 873.8m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 837.6m USD (calculated: Debt 873.8m - CCE 36.2m)
Enterprise Value = 1.18b USD (341.6m + Debt 873.8m - CCE 36.2m)
Interest Coverage Ratio = 0.09 (Ebit TTM 5.42m / Interest Expense TTM 57.4m)
EV/FCF = 35.61x (Enterprise Value 1.18b / FCF TTM 33.1m)
FCF Yield = 2.81% (FCF TTM 33.1m / Enterprise Value 1.18b)
FCF Margin = 26.11% (FCF TTM 33.1m / Revenue TTM 126.8m)
Net Margin = 2.70% (Net Income TTM 3.42m / Revenue TTM 126.8m)
Gross Margin = 72.92% ((Revenue TTM 126.8m - Cost of Revenue TTM 34.3m) / Revenue TTM)
Gross Margin QoQ = none% (prev 69.37%)
Tobins Q-Ratio = 0.74 (Enterprise Value 1.18b / Total Assets 1.60b)
Interest Expense / Debt = 6.57% (Interest Expense 57.4m / Debt 873.8m)
Taxrate = 36.85% (2.00m / 5.42m)
NOPAT = 3.42m (EBIT 5.42m * (1 - 36.85%))
Current Ratio = 1.21 (Total Current Assets 43.9m / Total Current Liabilities 36.4m)
Debt / Equity = 1.34 (Debt 873.8m / totalStockholderEquity, last quarter 652.9m)
Debt / EBITDA = 94.59 (Net Debt 837.6m / EBITDA 8.86m)
Debt / FCF = 25.30 (Net Debt 837.6m / FCF TTM 33.1m)
Total Stockholder Equity = 672.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.21% (Net Income 3.42m / Total Assets 1.60b)
RoE = 0.51% (Net Income TTM 3.42m / Total Stockholder Equity 672.4m)
RoCE = 0.35% (EBIT 5.42m / Capital Employed (Total Assets 1.60b - Current Liab 36.4m))
RoIC = 0.22% (NOPAT 3.42m / Invested Capital 1.56b)
WACC = 5.20% (E(341.6m)/V(1.22b) * Re(7.87%) + D(873.8m)/V(1.22b) * Rd(6.57%) * (1-Tc(0.37)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.98 | Cagr: -0.26%
[DCF] Terminal Value 73.10% ; FCFF base≈39.5m ; Y1≈34.7m ; Y5≈28.0m
[DCF] Fair Price = N/A (negative equity: EV 449.7m - Net Debt 837.6m = -387.9m; debt exceeds intrinsic value)
EPS Correlation: -96.54 | EPS CAGR: -14.45% | SUE: 0.33 | # QB: 0
Revenue Correlation: -73.56 | Revenue CAGR: -13.23% | SUE: 0.03 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.35 | Chg30d=+0.00% | Revisions=-44% | Analysts=7
EPS current Year (2026-12-31): EPS=1.48 | Chg30d=+0.09% | Revisions=+25% | GrowthEPS=-18.0% | GrowthRev=-12.1%
EPS next Year (2027-12-31): EPS=1.41 | Chg30d=+0.41% | Revisions=+25% | GrowthEPS=-5.3% | GrowthRev=-2.1%
[Analyst] Revisions Ratio: -18% (up=3, down=5)